In Silico QT and APD Prolongation Assay for Early Screening of Drug-Induced Proarrhythmic Risk.Model evaluation · aurocArea under the curve (AUC) · PDF pp. 8
Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole.Model scenario comparison · peakArea under the curve (AUC), Pharmacokinetics and drug exposure · PDF pp. 6
Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs.Model scenario comparison · bioequivalence_interval_threshold_attainmentArea under the curve (AUC), Pharmacokinetics and drug exposure · PDF pp. 2
An In Silico Knockout Model for Gastrointestinal Absorption Using a Systems Pharmacology Approach - Development and Application for Ketones.Mechanism removal · time_to_peak_concentrationArea under the curve (AUC) · PDF pp. 13
An In Silico Knockout Model for Gastrointestinal Absorption Using a Systems Pharmacology Approach - Development and Application for Ketones.Mechanism removal · time_to_peak_concentrationArea under the curve (AUC) · PDF pp. 13
Trauma in silico: Individual-specific mathematical models and virtual clinical populations.Model evaluationCorrelation or agreement, Area under the curve (AUC) · PDF pp. 4